Clinical Trial Update: Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma [Phase 2]

View source ↗

Summary

This clinical trial update discusses Phase 2 research on sirolimus discontinuation strategies in Kaposiform Hemangioendothelioma. The study is currently not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: West China Hospital | Conditions: Kaposiform Hemangioendothelioma | Phase 2 | Status: NOT_YET_RECRUITING